BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc

The management of advanced nasopharyngeal carcinoma (NPC) remains a challenge. The ubiquitous nature of Epstein–Barr virus (EBV) infection in nonkeratinizing NPC has forced us to investigate novel drugs for NPC in the presence of EBV. In this study, we performed a small-scale screening of a library...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ning, Yang, Lu, Qi, Xue-Kang, Lin, Yu-Xin, Xie, Xinhua, He, Gui-Ping, Feng, Qi-Sheng, Liu, Ling-Rui, Xie, Xiaoming, Zeng, Yi-Xin, Feng, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037792/
https://www.ncbi.nlm.nih.gov/pubmed/29988031
http://dx.doi.org/10.1038/s41419-018-0789-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6037792/
https://www.ncbi.nlm.nih.gov/pubmed/29988031
http://dx.doi.org/10.1038/s41419-018-0789-1

Ejemplares similares